Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs WY✓SelectedUSD · WYGSK vs WY performance historyLatest closeAs of-0.08%11/16
Stock and ETF performance explorer

GSK vs WY

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+46.7%
WY return
-32.6%
Excess return
+79.3%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioWYExcessAlpha
1D-0.1%-0.6%+0.5%+0.1%
7D-1.3%-2.1%+0.8%-0.9%
30D+2.7%+5.5%-2.7%+1.5%
3M+2.7%-15.0%+17.7%+6.0%
6M+3.3%-7.2%+10.5%+4.7%
YTD+6.5%-10.4%+16.8%+8.5%
1Y+10.7%-3.1%+13.8%+11.0%
3Y+64.4%-28.4%+92.7%+72.4%
5Y+46.7%-34.2%+80.9%+53.4%
All+46.7%-32.6%+79.3%+53.4%

Cumulative growth

Daily Returns

Daily percentage return beside WY.

Daily Out/Under-Performance

Portfolio return minus WY return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × WY return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded WY wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling